Lifestyle and Adiponectin Level: Four-Year Follow-Up of Controlled Trials

    July 2010 in “ Archives of Internal Medicine ”
    Katherine Esposito
    TLDR Prostaglandins may protect hair follicles during chemotherapy.
    Hair follicles undergo anagen (growth), catagen (involution), and telogen (resting) phases. Chemotherapy-induced hair loss occurs due to disruption of mitosis in anagen-phase hair matrix cells, with scalp hair being highly affected as 85%-90% of scalp follicles are in the anagen phase. Combined chemotherapy with cyclophosphamide and doxorubicin caused hair loss in 92% of patients, with 69.5% experiencing complete alopecia. Prostaglandin analogs like latanoprost have been shown to increase eyelash number, thickness, and length by inducing follicles into the anagen phase. In an animal model, topical misoprostol before doxorubicin therapy increased residual hair. These findings suggest prostaglandins may protect hair follicles during chemotherapy, warranting further investigation.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 269 results

      community 5 Month Dutasteride Progress Before and After

      in Progress Pictures  173 upvotes 1 year ago
      A user experiencing significant hair loss started using Dutasteride, a drug typically used for prostate issues, and noticed a positive change in hair thickness and volume after 5 months. Other users in the conversation also shared their experiences and observations with Dutasteride, with one mentioning additional use of oral Minoxidil.

      community Losing gains from 7 months of oral min, fin, dut.

      in Update  66 upvotes 1 year ago
      A user reported losing hair after 7 months of using oral minoxidil, finasteride, and dutasteride, but others reassured that this is likely just a shedding phase where old hairs fall out to make way for new growth. Some users experience sheds every 7-8 months and suggest staying consistent with treatment.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  37 upvotes 1 year ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

      community Progress with 6 Years fin and a FUT (2017 vs 2023)

      in Is this regrowth?  210 upvotes 1 year ago
      The post discusses a user's six-year progress with finasteride and a Follicular Unit Transplant (FUT) for hair loss. The user shared before and after photos in reverse order, leading to confusion, but overall, the community responded positively to the user's hair regrowth.

    Similar Research

    6 / 1000+ results